knowledge -WSS

knowledge

author：fashion 2025-08-11 09:49:12 - browse：6215

Venture firms backing health tech startups are telegraphing cautious optimism for 2024, advising startups to expect smaller and fewer checks as well as possible market consolidation but not to abandon hope just yet as investments stabilize following a sharp drop-off.

As customers — often health systems, payers, or employers — and backers plot how they’ll invest shrinking budgets, they’re increasingly savvy about metrics, investors told STAT. They’re also less interested in rapid growth, and more keen on startups that can demonstrate savings and efficiency.

That’s a sharp contrast from the unrestrained health tech investments that peaked in 2021, fueled by a pandemic-era frenzy for virtual appointments, mental health care and app-based therapies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Coloradans with cystic fibrosis could lose access to Trikafta

leisure time

WSS

Medicare proceeds with plan to claw back hospital funds

The health care issue Democrats can’t solve: hospital reform

Coloradans with cystic fibrosis could lose access to Trikafta

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Prime Medicine says its gene editing passes test in monkeys

After Sarepta trial failure, Duchenne families brace for more debate

leisure time

knowledge

Wikipedia

Alkermes shareholders re

The health care issue Democrats can’t solve: hospital reform

State Dept. review finds Biden bears some blame for Afghanistan failures

Brain injuries and the importance of a second opinion

Moonlake's readout produced a cash windfall. Risks remain

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Guidelines to prevent youth baseball injuries need more muscle

Gene therapy’s promise and the high cost of hope

Virginia high school admissions case could be legal follow

How neuroscience research could help beat back brain cancer

Wikipedia

After Sarepta trial failure, Duchenne families brace for more debate

Live blog: Hearing on CRISPR

Key Senate panel to consider PBM, drug pricing reform package

Prime Medicine says its gene editing passes test in monkeys

What is microchimerism and how does it affect maternal health?

Humans aren't the only ones with an imagination. Rats have it too

knowledge

knowledge

leisure time

hotspot